# Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD

> **NCT05018845** · PHASE1 · RECRUITING · sponsor: **The Foundation for Orthopaedics and Regenerative Medicine** · enrollment: 20 (estimated)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **BIOLOGICAL:** AlloRx

## Key facts

- **NCT ID:** NCT05018845
- **Lead sponsor:** The Foundation for Orthopaedics and Regenerative Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-06
- **Primary completion:** 2025-11
- **Final completion:** 2025-11
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05018845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05018845, "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05018845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*